What Is DXCM Fair Value?
Dexcom (DXCM) fair value estimate using multiple valuation models, updated daily.
As of July 16, 2026, Dexcom (DXCM) has a composite fair value estimate of $68.21 based on four valuation models: DCF (41% weight), Graham Number (29% weight), PEG (29% weight), and DDM (0% weight). The current market price is $72.73, suggesting the stock is fair value by 6.2%.
Data as of July 16, 2026 (today)
Composite Fair Value
Fair Value3 of 4 models$68.21
vs. current price of $72.73(-6.2%)
How Is DXCM Fair Value Calculated?
Four independent models estimate what DXCM is worth. Each uses different inputs and assumptions. The composite blends them by weight.
DXCM Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
41% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$94.38
+29.8%Undervalued
Inputs used
DDM (Dividend Discount Model)
0% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
N/A
This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.
DXCM Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
29% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$21.13
-71.0%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
29% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$55.33
-23.9%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $72.73 is 29.8% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.28B | $1.14B |
| Year 2 | $1.56B | $1.24B |
| Year 3 | $1.89B | $1.34B |
| Year 4 | $2.29B | $1.45B |
| Year 5 | $2.78B | $1.57B |
| Year 6 | $3.38B | $1.70B |
| Year 7 | $4.10B | $1.84B |
| Year 8 | $4.98B | $2.00B |
| Year 9 | $6.04B | $2.16B |
| Year 10 | $7.33B | $2.34B |
| Terminal Value | $78.33B | $25.02B |
What Are DXCM's Key Financial Metrics?
Earnings & Growth
Current Price
$72.73
EPS (TTM)
$2.28
Forward P/E
23.6
Profit Margin
19.3%
Cash & Balance Sheet
Free Cash Flow
1.1B
EBITDA
1.3B
Book Value
$7.66
Total Debt
1.4B
What Do Analysts Say About DXCM?
Low
$65.00
Average
$85.46
High
$112.00
Upside
+17.5%
DXCM Fair Value FAQ
What is the fair value of DXCM?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), DXCM's estimated fair value is $68.21. The stock is currently trading at $72.73, which makes it fair value by our analysis.
How is DXCM's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is DXCM overvalued or undervalued?
Based on our analysis, DXCM is fair value. The current price of $72.73 is 6.2% above our estimated fair value of $68.21.
What do Wall Street analysts say about DXCM?
24 analysts cover Dexcom with a consensus rating of "Strong Buy." The average price target is $85.46, ranging from $65.00 to $112.00. This implies 17.5% upside from the current price.